|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.99 CHF | -0.87% |
|
-1.72% | +18.22% |
| 05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
| 05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Sandoz announced sales results for the first quarter 2024. For the period, the company announced net sales of USD 2,492 million against USD 2,384 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.22% | 15.15B | |
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B | |
| +6.11% | 4.77B |
SANDOZ GROUP AG 
